FDA Strikes Down Eli Lilly’s Application Seeking Approval For Ulcerative Colitis Drug
The FDA has issued a complete response letter for Eli Lilly And Co’s (NYSE:LLY) mirikizumab biologic license application (BLA) for ulcerative colitis…
Citigroup Q1 Result Tops Estimates, Net Interest Income Up 23%
Citigroup Inc (NYSE:C) reported first-quarter FY23 net revenue growth of 12% year-over-year to $21.45 billion, beating the consensus of $20.03 billion.…
Major Bank Profits Surge More Than Expected In Q1, Drawing Customer Deposits From Smaller Players
Major U.S. financial institutions JP Morgan Chase & Co. (NYSE: JPM), Wells Fargo & Company (NYSE: WFC), BlackRock, Inc. (NYSE:
UnitedHealth Posts Q1 Profit Of $5.6B On Strong Optum, Health Plans; Lifts Earnings Outlook
UnitedHealth Group Inc (NYSE:UNH) has reported Q1 FY23 sales of $91.9 billion, up 15% Y/Y, beating the consensus of $89.77…
Wells Fargo Q1 Results Beat Expectations, Net Interest Income Jumps 45%
Wells Fargo & Co (NYSE: WFC) shares are up 3% premarket Friday following its solid first-quarter results that beat Street expectations.
BlackRock’s Q1 Earnings: Revenue and AUM Decline, Net Inflow Rises, $32B Bond ETF Inflow
BlackRock Inc (NYSE:BLK) reported a Q1 revenue decline of 10% Y/Y to $4.24 billion, slightly below the consensus of $4.25…
Analyst Says QuidelOrtho’s Interim Earnings Update Should ‘Ease Some Investor Fears’
QuidelOrtho Corporation (NASDAQ:QDEL) expects total revenues in Q1 FY23 to be $840 million-$850 million, compared to the consensus of $746.75…
Analysts Says Stat News Article Adds Uncertainty To Sarepta’s SRP-9001, But Offers Buying Opportunity Around The Weakness
Earlier today, an article was published by Stat News noting that reviewers at the FDA were leaning toward…
Dick’s Sporting Goods Becomes Official Sponsor Of Boston Marathon, Following NCAA Sponsorship Win
Dick’s Sporting Goods Inc (NYSE:DKS) inked a multi-year sponsorship partnership with Boston Athletic Association (BAA). As per the deal, DKS…
Jassy Addresses Cost-Cutting, Generative AI In Amazon Shareholder Letter: What Investors Need To Know
Amazon.com, Inc (NASDAQ: AMZN) CEO Andy Jassy addressed the company's short-term headwinds, continued investment in growth areas, cost control measures and generative AI in his annual shareholder letter Thursday. Here’s a breakdown of what the CEO had to s